VYNE THERAPEUTICS INC (YARW)
Institutional ownership reported to the SEC as of Q2 2022, across 6 quarters.
1
Reporting holders
$10.0K
Reported value
100.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| SIMPLEX TRADING, LLC | $10.0K | options only | 0.00% | 6q | OPTIONS |
Five percent filings
Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →
| Filed | Form | Filer | % of class |
|---|---|---|---|
| 2026-08-07 | 13G/A | Logos Global Management LPwith 7 co-filers | 10.7% |
| 2026-08-07 | 13G | JANUS HENDERSON GROUP Ltd. | 10.0% |
| 2026-08-05 | 13D | ORBIMED ADVISORS LLCwith 3 co-filers | 10.0% |
| 2026-08-04 | 13G | Logos Global Management LPwith 7 co-filers | 9.9% |
| 2026-08-03 | 13G | Perceptive Advisors LLCwith 2 co-filers | 10.0% |
| 2026-07-30 | 13G | RTW Fund Group GP, LLCwith 1 co-filers | 10.0% |
| 2026-07-29 | 13D/A | AI Biotechnology LLCwith 3 co-filers | 6.0% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2022 | 1 | $10.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2022 | 1 | $19.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2021 | 1 | $6.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2021 | 1 | $82.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2021 | 1 | $83.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2021 | 1 | $120.0K | 0 | 2 | 0 | 0 | 100.0% |